Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Will The Decline in Legacy Drugs Pull Down BMY's Top Line?
10:30am, Thursday, 03'rd Jul 2025
Bristol Myers' legacy drug sales plunged 20% amid generic erosion and Medicare changes, spotlighting its shift to a newer growth portfolio.
Bristol Myers Squibb (BMY) Ascends While Market Falls: Some Facts to Note
06:45pm, Tuesday, 01'st Jul 2025
Bristol Myers Squibb (BMY) closed at $47.51 in the latest trading session, marking a +2.64% move from the prior day.
Bristol-Myers Squibb: Strong Launch Portfolio Amid Market Reset
06:25am, Tuesday, 01'st Jul 2025
Initiate Bristol-Myers Squibb (BMY) with Buy and $57 PT, driven by high-momentum launches, robust pipeline, and underappreciated growth portfolio outperformance. BMY's $13bn+ annual FCF, strong balanc
BMY Loses 16.3% YTD: Should You Buy, Sell or Hold the Stock?
10:50am, Monday, 30'th Jun 2025
BMY loses 16.3% YTD as pipeline setbacks and generic pressure offset gains from new drug approvals and sales.
Time to Sell the Rally and Buy These 5% and Higher Blue-Chip Dividend Giants
07:16am, Monday, 30'th Jun 2025
Investors love dividend stocks, especially the blue-chip variety, because they offer a significant income stream and have massive total return potential.
Bristol-Myers Squibb: You Might Wish You Bought More Now (Upgrade)
09:00am, Sunday, 29'th Jun 2025
Bristol-Myers Squibb faces structural headwinds from legacy product losses, but its strong free cash flow and undervalued stock price provide downside protection. The recent $11B partnership with BioN
5 of the Safest Strong-Buy High-Yield Dividend Stocks Are On Sale Now
08:43am, Saturday, 28'th Jun 2025
Investors love dividend stocks, especially high-yield ones, because they offer a significant income stream and have substantial total return potential.
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Abecma--U.S. FDA Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb's Cell Therapy Labels.
This Once Dominant Dividend Stock May Be About to Come Back to Life in July
11:59am, Thursday, 26'th Jun 2025
For income investors seeking a timely value stock to buy on the dip, former dividend darling Bristol-Myers Squibb (NYSE:BMY) may fit the bill as one of the top names to watch in the month of July.
Will New Drugs Enable BMY to Offset the Impact of Generic Competition?
11:05am, Wednesday, 25'th Jun 2025
BMY depends on Reblozyl, Opdualag and Breyanzi to offset revenue hits from generics and Medicare Part D impacts.
Cigna sues Bristol Myers over alleged monopoly for multiple myeloma drug Pomalyst
11:58am, Tuesday, 24'th Jun 2025
Cigna sued Bristol Myers on Tuesday, accusing the drugmaker of violating federal antitrust law by maintaining a monopoly over a blockbuster multiple myeloma drug sold under the brand name Pomalyst.
10 'Safer' Dividend Buys Of Barron's Better Bets Than T-Bills For June
10:16am, Tuesday, 24'th Jun 2025
Long-term bond yields continue to rise. But investors looking for income can still find plenty of attractive opportunities with dividend-paying stocks that have healthy yields. “23 stocks pay huge d
Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock
10:00am, Tuesday, 24'th Jun 2025
Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Bargain Alert: I'm Buying Monthly Dividends Up To 7% Yield
09:00am, Tuesday, 24'th Jun 2025
Timing of income is an important consideration. Monthly dividend stocks provide recurring income and faster compounding of wealth. I highlight two monthly dividend payers that are undervalued while su
2 Dividend Aristocrats Bargains To Buy And 'Never Let Go'
08:00am, Tuesday, 24'th Jun 2025
Buying Dividend Aristocrats at bargain prices can be a winning investment strategy. I highlight two such names that are undervalued compared to historical norms while paying strong and well-covered di
